V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001020 | 230000607 | null | 73.6 | Palliative (P) | 2019-07-08 | 2019-07-21 | Amsacrine + FLUOROURACIL + IRINOTECAN + OXALIPLATIN | null | null | 230012332 | DOCETAXEL |
| 230001021 | 230000608 | null | 93.4 | Palliative (P) | 2018-10-05 | 2018-10-11 | Capecitabine + Oxaliplatin 21day | N | null | 230012425 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 230001022 | 230000608 | 1.5 | 74.6 | Adjuvant (A) | 2015-12-12 | 2015-12-29 | EOX | 02 | N | 230012425 | CAPECITABINE + OXALIPLATIN |
| 230001023 | 230000609 | 1.71 | null | Not known (9) | null | 2017-09-10 | Fluorouracil + Folinic Acid Weekly | Y | null | 230012434 | PACLITAXEL |
| 230001024 | 230000610 | 1.8 | 78 | Curative (C) | 2016-09-23 | 2016-10-05 | CARBOPLATIN + PACLITAXEL | 02 | Y | 230012552 | CAPECITABINE + OXALIPLATIN |
| 230001025 | 230000610 | 1.63 | 62.7 | null | 2017-12-24 | 2017-12-25 | Capecitabine | 02 | N | 230012552 | PEG INTERFERON |
| 230001026 | 230000611 | 1.59 | 73.4 | Palliative (P) | 2019-07-31 | 2019-08-05 | Cisplatin + Radiotherapy | N | null | 230012938 | IRINOTECAN + MDG |
| 230001027 | 230000611 | 1.66 | 88.6 | Palliative (P) | 2019-02-07 | 2019-03-01 | Capecitabine + Oxaliplatin 21day | N | N | 230012938 | SORAFENIB |
| 230001028 | 230000611 | 1.57 | 93.6 | Adjuvant (A) | 2018-04-10 | 2018-04-10 | Fluorouracil+Mitomycin+RT (Anal Ca) | null | N | 230012938 | CISPLATIN |
| 230001029 | 230000612 | 1.55 | 58.2 | Palliative (P) | 2017-11-10 | 2017-11-10 | Sorafenib | 02 | N | 230013561 | CISPLATIN + PEMETREXED |
| 230001030 | 230000612 | 1.53 | null | Curative (C) | 2015-02-18 | 2015-03-05 | FEC + TRASTUZUMAB | N | Y | 230013561 | ECARBOF |
| 230001031 | 230000612 | 1.75 | 103 | null | 2016-11-13 | 2016-11-25 | Oxaliplatin + Modified de Gramont | 02 | N | 230013561 | DOXORUBICIN |
| 230001032 | 230000613 | 1.73 | 97.1 | null | 2019-02-19 | 2019-02-19 | Doxorubicin 75mg/m2 | N | N | 230013809 | SORAFENIB |
| 230001033 | 230000614 | 1.51 | 47.6 | Not known (9) | 2018-11-05 | 2018-11-16 | Irinotecan + Modified De Gramont | 02 | N | 230014077 | CHOP R |
| 230001034 | 230000615 | 1.62 | 68 | Curative (C) | null | 2017-07-23 | Oxaliplatin + Modified de Gramont | N | N | 230014299 | CARBOPLATIN + LIPOSOMAL DOX |
| 230001035 | 230001280 | 1.59 | 75.3 | Adjuvant (A) | 2018-06-13 | 2018-06-27 | Oxaliplatin + Modified de Gramont | N | N | 230014743 | CARBOPLATIN + ETOPOSIDE |
| 230001036 | 230001280 | null | 59.3 | Neo-adjuvant (N) | 2019-07-06 | 2019-07-18 | Cisplatin + Doxorubicin | N | N | 230014743 | VANDETANIB |
| 230001037 | 230000616 | 1.67 | 94 | Curative (C) | 2019-01-25 | 2019-02-21 | Capecitabine | 02 | null | 230018789 | CHOP R |
| 230001038 | 230000617 | 1.68 | 72.2 | Curative (C) | 2016-09-03 | 2016-09-25 | Carboplatin + Paclitaxel (3 weekly) | N | Y | 230019117 | CAPECITABINE |
| 230001039 | 230001281 | 1.63 | 64.5 | Curative (C) | 2016-07-10 | 2016-07-23 | CAPECITABINE + OXALIPLATIN | 02 | N | 230020173 | DOCETAXEL |
| 230001040 | 230001281 | 1.68 | 98 | Adjuvant (A) | 2014-06-20 | 2014-07-12 | Capecitabine + Oxaliplatin 21day | 2 | N | 230020173 | CISPLATIN + GEMCITABINE |
| 230001041 | 230001281 | 1.67 | 66.5 | Adjuvant (A) | 2018-05-19 | 2018-06-06 | Cisplatin + Docetaxel +Fluorouracil | N | N | 230020173 | CISPLATIN + DOXORUBICIN |
| 230001042 | 230001281 | 1.68 | 0 | Palliative (P) | 2016-11-13 | 2016-11-20 | FLUOROURACIL | 02 | N | 230020173 | SORAFENIB |
| 230001043 | 230001281 | 1.77 | 84.5 | Palliative (P) | 2015-10-27 | 2015-10-31 | Fluorouracil + Folinic + RT Bossett | 02 | N | 230020173 | DOCETAXEL |
| 230001044 | 230000618 | null | 113.8 | Adjuvant (A) | 2013-10-03 | 2014-03-25 | Capecitabine + Oxaliplatin 21day | 2 | N | 230024525 | CISPLATIN + GEMCITABINE |
| 230001045 | 230001282 | null | null | Palliative (P) | null | 2014-06-29 | Oxaliplatin + Modified de Gramont | N | N | 230026193 | DOXORUBICIN |
| 230001046 | 230001282 | 1.54 | 57.5 | Adjuvant (A) | 2015-08-27 | 2015-09-16 | Rituximab | 2 | Y | 230026193 | FLUOROURACIL + MITOMYCIN + RT |
| 230001047 | 230001282 | 1.69 | 78.2 | Adjuvant (A) | 2018-04-06 | 2018-04-20 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | N | 230026193 | CTD |
| 230001048 | 230000619 | 1.8 | 87 | Curative (C) | 2014-11-20 | 2014-12-30 | LENVATINIB | N | Y | 230001080 | CARBOPLATIN + PEMETREXED |
| 230001049 | 230000620 | 1.56 | 53.6 | Adjuvant (A) | 2018-10-29 | 2018-10-29 | Cisplatin +Fluorouracil (3 wk) | N | N | 230004040 | BENDAMUSTINE + RITUXIMAB |
| 230001050 | 230001283 | null | 48.2 | Palliative (P) | 2018-12-13 | 2018-12-20 | TEMOZOLOMIDE | 02 | N | 230007852 | CISPLATIN |
| 230001051 | 230001283 | 1.65 | null | Palliative (P) | 2017-06-15 | 2017-07-07 | FLUOROURACIL + MITOMYCIN | N | null | 230007852 | CAPECITABINE |
| 230001052 | 230001283 | 1.54 | 70 | Palliative (P) | 2018-10-10 | 2018-10-24 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | 230007852 | CTD |
| 230001053 | 230001716 | 1.8 | 84.5 | Not known (9) | 2018-02-02 | 2018-02-20 | CHOP R - 21 days | N | N | 230013963 | CVP R |
| 230001054 | 230000621 | null | 65 | Curative (C) | 2017-01-05 | 2017-01-12 | STAR TRIAL | 02 | N | 230023180 | FLUOROURACIL + MITOMYCIN + RT |
| 230001055 | 230000621 | -1 | 102.9 | Curative (C) | 2018-06-16 | 2018-06-23 | Capecitabine + Oxaliplatin 21day | 2 | null | 230023180 | CARBOPLATIN + ETOPOSIDE |
| 230001056 | 230000621 | 1.68 | 62.2 | Curative (C) | 2015-02-01 | 2015-02-01 | Capecitabine | N | Y | 230023180 | STAR TRIAL |
| 230001057 | 230000622 | 1.77 | 97.6 | Palliative (P) | 2015-04-24 | 2015-05-12 | Sorafenib | 02 | N | 230001129 | FEC |
| 230001058 | 230000623 | 1.9 | 95 | Adjuvant (A) | null | 2018-04-21 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 2 | N | 230014716 | OXALIPLATIN + MDG |
| 230001059 | 230000624 | 1.62 | null | Adjuvant (A) | null | 2016-11-24 | PACLITAXEL | Y | N | 230014739 | EC |
| 230001060 | 230000624 | 1.71 | 73.15 | Adjuvant (A) | null | 2016-09-01 | PEMBROLIZUMAB | null | N | 230014739 | CAPECITABINE + OXALIPLATIN |
| 230001061 | 230000627 | 1.56 | null | Palliative (P) | 2018-12-29 | 2019-01-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | 230014868 | IRINOTECAN + MDG |
| 230001062 | 230000630 | 1.63 | 102 | Palliative (P) | 2018-05-04 | 2018-05-18 | LENVATINIB | 02 | N | 230015009 | TRIFLURIDINE + TIPIRACIL |
| 230001063 | 230000633 | 1.57 | 71.3 | Palliative (P) | 2018-08-06 | 2018-08-14 | LENVATINIB | N | N | 230015348 | AFLIBERCEPT + FU + IRINOTECAN |
| 230001064 | 230000634 | 1.56 | 68 | Palliative (P) | 2015-03-20 | 2015-03-30 | CARBOPLATIN + ETOPOSIDE | N | N | 230015520 | CAPECITABINE |
| 230001065 | 230000636 | null | 65.8 | Palliative (P) | 2014-04-30 | 2014-05-10 | Oxaliplatin + Modified de Gramont | N | N | 230015621 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 230001066 | 230000637 | 1.73 | 92.7 | Adjuvant (A) | 2014-08-27 | 2014-09-02 | Enzalutamide | 2 | N | 230015621 | IRINOTECAN + MDG |
| 230001067 | 230000637 | 1.79 | 85.9 | Disease modification (D) | 2016-11-21 | 2016-11-26 | Bevacizumab + Oxaliplatin +MdG | 02 | N | 230015621 | CETUXIMAB + IRINOTECAN + MDG |
| 230001068 | 230000638 | 1.8 | 78.8 | null | 2015-11-27 | 2015-12-13 | CETUXIMAB | 02 | N | 230016090 | AFLIBERCEPT + FU + IRINOTECAN |
| 230001069 | 230000638 | 1.52 | null | Palliative (P) | 2018-03-01 | 2018-02-25 | LENVATINIB | 02 | null | 230016090 | IRINOTECAN + MDG |